Eli Lilly
3,920 hedge funds and large institutions have $689B invested in Eli Lilly in 2025 Q1 according to their latest regulatory filings, with 250 funds opening new positions, 1,798 increasing their positions, 1,410 reducing their positions, and 171 closing their positions.
46% more first-time investments, than exits
New positions opened: 250 | Existing positions closed: 171
28% more repeat investments, than reductions
Existing positions increased: 1,798 | Existing positions reduced: 1,410
18% more funds holding in top 10
Funds holding in top 10: 337 → 399 (+62)
14% more capital invested
Capital invested by funds: $606B → $689B (+$83.2B)
5.91% more ownership
Funds ownership: 82.33% → 88.24% (+5.9%)
0% more funds holding
Funds holding: 3,907 → 3,920 (+13)
7% less call options, than puts
Call options by funds: $9.22B | Put options by funds: $9.88B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$41.6B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$4.15B |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.14B |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$951M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$901M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$2.25B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.72B |
| 3 |
Primecap Management
Pasadena,
California
|
-$1.64B |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.44B |
| 5 |
JP Morgan Chase
New York
|
-$1.19B |
LLY Hedge Fund Activity: Q1 2025 in Review
3,920 of the 7,460 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q1 2025, worth a combined $689B — up 14% from $606B a quarter earlier.
Buyers outnumbered sellers: 250 funds opened new LLY positions and 171 closed out — a net gain of 79 holders — while 1,798 added to existing stakes and 1,410 trimmed.
The largest buyer was PNC Financial Services Group, adding an estimated $41.6B. The largest seller was GQG Partners, cutting an estimated $2.25B.
- 3,920 institutional investors held Eli Lilly (LLY) as of Q1 2025, up from 3,907 in Q4 2024.
- Funds reported $689B of Eli Lilly stock for Q1 2025, up 14% quarter-over-quarter.
- 250 funds opened new Eli Lilly positions in Q1 2025 and 171 closed out, a net change of +79 holders.
- The largest Eli Lilly buyer in Q1 2025 was PNC Financial Services Group, an estimated $41.6B added.
- The largest Eli Lilly seller in Q1 2025 was GQG Partners, an estimated $2.25B sold.
Based on aggregated 13F filings for Q1 2025.